Core Insights - The article highlights the significant achievements of Jingtai Technology, particularly its autonomous experimental platform, which has gained national media attention and is set to be the first company to list on the Hong Kong Stock Exchange under the 18C rule in 2024 [1][5] Company Developments - Jingtai Technology's autonomous experimental platform replaces traditional manual operations with robots, enhancing precision and safety while collecting data for AI model training [5][6] - The company is involved in the construction of a "Four Modernizations Platform" for traditional Chinese medicine (TCM) drug development, integrating AI and automation throughout the entire process [5][6] - The "Four Modernizations Platform" is recognized as the world's first fully automated platform for analyzing effective active ingredients in TCM, setting a new industry standard [6] Social Responsibility Initiatives - Jingtai Technology actively engages in social responsibility, organizing events to support autism awareness and providing educational resources to underprivileged children [7][8] - The company collaborates with various organizations to promote science education and awareness, particularly among youth and marginalized communities [8] Organizational Development - The party branch of Jingtai Technology integrates party work with corporate development, fostering innovation and collaboration among technical talents [9][10] - The company has received multiple honors for its organizational efforts, including recognition as an advanced grassroots party organization [10] Future Directions - Jingtai Technology plans to deepen its collaboration in the Shenzhen-Hong Kong Innovation and Technology Cooperation Zone, focusing on AI and biomedicine innovations while leveraging policy advantages to enhance productivity [11]